| Literature DB >> 21206988 |
G Gross1.
Abstract
Despite some recent hopeful therapeutic developments such as topical green tea derivatives, the therapy of anogenital warts remains a medical problem. Both physician- and self-administered therapeutic approaches are not fully satisfactory. The high recurrence rates associated with the current therapy of anogenital warts together with their increasing incidence and burden of disease further support the use of the prophylactic quadrivalent VLP HPV 6,11,16,18 vaccine for control of HPV-associated neoplasias in women and men.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21206988 DOI: 10.1007/s00105-010-2036-2
Source DB: PubMed Journal: Hautarzt ISSN: 0017-8470 Impact factor: 0.751